Skip to main content

Children’s Tumor Foundation Announces “Innovative Business Opportunities for NF” Meeting

We invite Business Development executives to this unique and important “Innovative Business Opportunities for NF” meeting, which will be held on the afternoon of June 9th (2 – 4 p.m.). The meeting will kick off with a presentation from Foundation President and Chief Scientific Officer, Annette Bakker, during which she will highlight CTF’s activities in its relations with industry — bridging academia with pharma/biotech, and the critical need for drugs to enter the pipeline. Her overview will be followed by a compelling presentation by Foundation consultant, David Lapidus, on the NF market model.

A panel discussion will then follow, moderated by Randall Stanicky, RBC Managing Director, Global Equity Research – Specialty Pharmaceuticals. Through the expertise and experience of our panelists, the goal will be to clearly affirm that:

Innovative models are applied in industry to better match patient needs with business opportunities – Mark DeSouza, PhD, CEO, desouzatech
Other successful disease foundations have adopted business models that efficiently translate research findings into clinical benefit – Margaret Anderson, Executive Director, FasterCures
There is a well-defined clinical need and a path to approval for NF – REiNS (“Response Evaluation in Neurofibromatosis and Schwannomatosis”), Scott Plotkin, MD, PhD, Director, Neurofibromatosis Clinic, Massachusetts General Hospital and Chairperson, REiNS
It is possible to make an NF business case – David Lapidus, Principal, LapidusData LLC
Companies have interest in NF – Gideon Bollag, PhD, CEO, Plexxikon
The investor’s position on rare disease and NF – Sarah Nayeem, MD, Principal, New Enterprise Associates

Registration fee – $100, includes entry to the Tuesday session featuring presentations on preclinical and clinical testing of NF-relevant molecules. Free of charge for registered NF Conference attendees.

For more information and to register, contact Patrice Pancza at

For more information on the NF Conference, click here.